David A. Siegel Compugen LTD Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Compugen LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 133,384 shares of CGEN stock, worth $222,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,384
Previous 213,084
37.4%
Holding current value
$222,751
Previous $421,000
18.29%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CGEN
# of Institutions
80Shares Held
13.7MCall Options Held
131KPut Options Held
76K-
Taylor Frigon Capital Management LLC1.32MShares$2.21 Million1.64% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.3MShares$2.17 Million0.01% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD1.29MShares$2.15 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.04MShares$1.74 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.7 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $145M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...